5/1/2023
•
Posted by Provider Relations
in
Provider News
The following sections of the Fidelis Care authorization grids have been updated effective June 1, 2023.
The Medicaid grid has been updated as follows:
D. Skin surgery and other dermatological procedures:
- Only the following codes continue to require authorization for any place of service: 11200, 11201, 11719 (new code), 15769-15829, 17340-17999
The following codes have been updated on the Medicaid, Medicare, Essential Plan and Metal-Level Authorization Grids and require prior authorization:
C9145 aprepitant aponvie inj
C9146 mirvetuximab soravtansine-gynx inj (Elahere)
C9147 tremelimumab-actl inj (Imjudo)
C9148 teclistamab-cqyv inj (Tecvayli)
J0208 sodium thiosulfate
J0218 olipudase alfa-rpcp inj (Xenpozyme)
J1411 ertranacogene dezaparvovec-drlb (Hemgenix)
J1449 eflapegrastim-xnst inj (Rolvedon)
J1747 spesolimab-sbzo (Spevigo)
J9196 gemcitabine (Gemzar-Accord)
J9294 pemetrexed inj (Hospira)
J9296 pemetrexed inj (Accord)
J9297 pemetrexed inj (Sandoz)
Q5127 pegfilgrastim-fpgk inj (Stimufend)
Q5128 ranibizumab-eqrn (Cimerli)
Q5129 bevacizumab-adcd inj (Vegzelma)
Q5130 pegfilgrastim-pbbk inj (Fylnetra)
The following code has been updated on the Medicaid, Essential Plan and Metal-Level Authorization Grids and requires prior authorization:
J1729 hydroxyprogesterone caproate injection
The following codes have been updated on the Medicaid Authorization Grid and require prior authorization:
C9149 teplizumab-mzwv (Tzield)
J9314 pemetrexed inj (Teva)
The following codes have been updated on the Medicare Authorization Grid and require prior authorization:
C9149 teplizumab-mzwv (Tzield)
J1729 hydroxyprogesterone caproate injecton
Visit: Authorization Grids